iBio, Inc. (IBIO)

NASDAQ: IBIO · Real-Time Price · USD

0.7356

+0.0089 (1.22%)

At close: Jul 22, 2025, 4:00 PM

0.7376

+0.0020 (0.27%)

After-hours: Jul 22, 2025, 7:48 PM EDT

Revenue by Product

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2017 - 2019
Precision Antibodies	225.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceuticals (iBio Inc.)	-	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceuticals (iBio Inc.) Growth	-	Log In	Log In	Log In	Log In	Upgrade
Bioprocessing (iBio CDMO)	-	Log In	Log In	Log In	Log In	Upgrade
Bioprocessing (iBio CDMO) Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2017 - 2019
United States	225.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-90.56%	Log In	Log In	Log In	Log In	Upgrade